---
title: "Nateglinide - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db00731-mesh-d003924-1.html
toc: false 
---


Path ID: `DB00731_MESH_D003924_1`
{% include image.html url="images/db00731-mesh-d003924-1.png" file="db00731-mesh-d003924-1.png" alt="db00731-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C060142">MESH:C060142 </a> | Nateglinide | Drug |
| <a href="https://identifiers.org/UniProt:Q09428">UniProt:Q09428 </a> | ATP-binding cassette sub-family C member 8 | Protein |
| <a href="https://identifiers.org/GO:0005267">GO:0005267 </a> | Potassium channel activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0060081">GO:0060081 </a> | Membrane hyperpolarization | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070509">GO:0070509 </a> | Transmembrane calcium influx | BiologicalProcess |
| <a href="https://identifiers.org/GO:0030073">GO:0030073 </a> | Insulin secretion | BiologicalProcess |
| <a href="https://identifiers.org/HP:0003074">HP:0003074 </a> | Hyperglycemia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003924">MESH:D003924 </a> | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nateglinide | DECREASES ACTIVITY OF | Atp-Binding Cassette Sub-Family C Member 8 |
| Atp-Binding Cassette Sub-Family C Member 8 | REGULATES | Potassium Channel Activity |
| Potassium Channel Activity | PARTICIPATES IN | Membrane Hyperpolarization |
| Membrane Hyperpolarization | NEGATIVELY REGULATES | Transmembrane Calcium Influx |
| Transmembrane Calcium Influx | POSITIVELY REGULATES | Insulin Secretion |
| Insulin Secretion | NEGATIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | MANIFESTATION OF | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00731](https://go.drugbank.com/drugs/DB00731)
